Trial Profile
Sunitinib prior to nephrectomy in patients with metastatic renal cell carcinoma and the primary tumor in situ.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Jul 2011
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 11 Jul 2011 New trial record